Click here for Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
The use of Prevenar 13 should be determined on the basis of official recommendations taking into consideration the risk of invasive disease and pneumonia in different age groups, underlying comorbidities as well as the variability of serotype epidemiology in different geographical areas1.
Access information about who may benefit from a private Prevenar 13 vaccination
Access information about where Prevenar 13 fits into the UK national immunisation programme here
Book your appointment
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020